ArticleKidney medicine2023

Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.